Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Tołoczko-Grabarek, Aleksandra
100  Ergebnisse:
Personensuche X
?
1

Influence of Muscle Mass and Strength on Bone Mineralisatio..:

Patalong-Wójcik, Martyna ; Golara, Anna ; Zając, Katarzyna...
Biomedicines.  11 (2023)  6 - p. 1574 , 2023
Link: https://doi.org/10.3390/..
 
?
2

Pilot Study: FSHR Expression in Neuroendocrine Tumors of th..:

Starzyński, Dariusz ; Rzeszotek, Sylwia ; Kolasa, Agnieszka...
Journal of Clinical Medicine.  12 (2023)  15 - p. 5086 , 2023
Link: https://doi.org/10.3390/..
 
?
3

Preoperative Serum Levels of PDGF-AB, PDGF-BB, TGF-α, EGF a..:

Kozłowski, Mateusz ; Borzyszkowska, Dominika ; Mirko, Justyna...
Cancers.  15 (2023)  19 - p. 4815 , 2023
Link: https://doi.org/10.3390/..
 
?
4

Germline HOXB13 mutation p.G84E do not confer an increased ..:

Złowocka-Perłowska, Elżbieta ; Tołoczko-Grabarek, Aleksandra ; Lubiński, Jan
Hereditary Cancer in Clinical Practice.  20 (2022)  1 - p. , 2022
Link: https://doi.org/10.1186/..
 
?
5

Germline BRCA1 and BRCA2 mutations and the risk of bladder ..:

Złowocka-Perłowska, Elżbieta ; Tołoczko-Grabarek, Aleksandra ; Narod, Steven A..
Hereditary Cancer in Clinical Practice.  20 (2022)  1 - p. , 2022
Link: https://doi.org/10.1186/..
 
?
6

Association of recurrent mutations in BRCA1, BRCA2, RAD51C,..:

Ogrodniczak, Alicja ; Menkiszak, Janusz ; Gronwald, Jacek...
Hereditary Cancer in Clinical Practice.  20 (2022)  1 - p. , 2022
Link: https://doi.org/10.1186/..
 
?
7

Bladder cancer survival in patients with NOD2 or CDKN2A var..:

Złowocka-Perłowska, Elżbieta ; van de Wetering, Thierry ; Tołoczko-Grabarek, Aleksandra..
Oncotarget.  13 (2022)  1 - p. 628-640 , 2022
Link: https://doi.org/10.18632..
 
?
8

Recurrent Mutations in BRCA1, BRCA2, RAD51C, PALB2 and CHEK..:

Łukomska, Alicja ; Menkiszak, Janusz ; Gronwald, Jacek...
Cancers.  13 (2021)  4 - p. 849 , 2021
Link: https://doi.org/10.3390/..
 
?
9

Survival of bladder or renal cancer in patients with CHEK2 ..:

Złowocka-Perłowska, Elżbieta ; Dębniak, Tadeusz ; Słojewski, Marcin...
PLOS ONE.  16 (2021)  9 - p. e0257132 , 2021
Link: https://doi.org/10.1371/..
 
?
10

A combination of the immunohistochemical markers CK7 and SA..:

Meagher, Nicola S. ; Wang, Linyuan ; Rambau, Peter F....
Modern Pathology.  32 (2019)  12 - p. 1834-1846 , 2019
Link: https://doi.org/10.1038/..
 
?
11

Review Selenium as a marker of cancer risk and of selection..:

Lener, Marcin ; Muszyńska, Magdalena ; Jakubowska, Anna...
Współczesna Onkologia.  1A (2015)  - p. 60-61 , 2015
Link: https://doi.org/10.5114/..
 
?
12

Serum HE4, CA125, YKL-40, bcl-2, cathepsin-L and prediction..:

Chudecka-Głaz, Anita ; Cymbaluk-Płoska, Aneta ; Menkiszak, Janusz...
Journal of Ovarian Research.  7 (2014)  1 - p. 62 , 2014
Link: https://doi.org/10.1186/..
 
?
13

Serum concentration of selected macro- and microelements an..:

Muszyńska, Magdalena ; Sukiennicki, Grzegorz ; Huzarski, Tomasz...
Hereditary Cancer in Clinical Practice.  10 (2012)  Suppl 3 - p. A17 , 2012
Link: https://doi.org/10.1186/..
 
?
14

Serum concentration of iron as predictor of cancer risk amo..:

Sukiennicki, Grzegorz ; Muszyńska, Magdalena ; Huzarski, Tomasz...
Hereditary Cancer in Clinical Practice.  10 (2012)  S3 - p. , 2012
Link: https://doi.org/10.1186/..
 
?
15

Plasma micronutrients, trace elements, and breast cancer in..:

Kotsopoulos, Joanne ; Sukiennicki, Grzegorz ; Muszyńska, Magdalena...
Cancer Causes & Control.  23 (2012)  7 - p. 1065-1074 , 2012
Link: https://doi.org/10.1007/..
 
1-15